These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27349720)

  • 1. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.
    Yang W; Li Y; Li P; Wang L
    Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic disulfide induces apoptosis of human diffuse large B cell lymphoma cells involving Bax cleavage.
    Wang L; Liu X; Li X; Lv X; Lu K; Chen N; Li P; Wang X
    Oncol Rep; 2013 Nov; 30(5):2427-34. PubMed ID: 24026139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
    Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
    Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
    Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
    Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
    Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
    Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.
    Jin Z; Qing K; Ouyang Y; Liu Z; Wang W; Li X; Xu Z; Li J
    J Exp Clin Cancer Res; 2016 Mar; 35():52. PubMed ID: 27009084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of AKT protein kinase activation on biologic behavior of diffuse large B cell lymphoma cells].
    Zhang TC; Zhou XY; Yu BH; Zhang TM; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 May; 36(5):318-23. PubMed ID: 17706139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas.
    Liu F; Zhang Y; Tang H; Zhou X; Wu Z; Tang D; Zhao T
    Oncol Rep; 2013 Aug; 30(2):783-92. PubMed ID: 23743627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cells.
    Han S; Tie X; Meng L; Wang Y; Wu A
    PLoS One; 2013; 8(10):e76717. PubMed ID: 24130787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways.
    Zhu Y; Lei C; Jiang Q; Yu Q; Qiu L
    Cancer Cell Int; 2022 Jul; 22(1):236. PubMed ID: 35883106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta.
    Afrasiabi E; Ahlgren J; Bergelin N; Törnquist K
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):26-35. PubMed ID: 18541361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
    Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
    Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
    Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
    BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis.
    Noori S; Hassan ZM
    Free Radic Biol Med; 2012 May; 52(9):1987-99. PubMed ID: 22366652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Z-VRPR-FMK can inhibit the growth and invasiveness of diffuse large B-cell lymphoma by depressing NF-κB activation and MMP expression induced by MALT1.
    Feng J; Yang W; Wang J; Pu Z; Han Y; Wan L
    Int J Clin Exp Pathol; 2019; 12(6):1947-1955. PubMed ID: 31934017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
    Feng L; Yan Q; Pan H; Shi W
    Immun Inflamm Dis; 2023 Feb; 11(2):e789. PubMed ID: 36840486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.
    Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D
    Cancer Cell; 2012 Dec; 22(6):825-37. PubMed ID: 23238017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.
    Yang H; Qiu B; Chen S; Xun Y; Pan Y; Chen M; Li WX; Liao W; El-Ashram S; Yang A; Liu F
    Cell Biol Int; 2019 Aug; 43(8):863-874. PubMed ID: 31033093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.